HeartBeam, Inc.
BEAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001779372
No open-market purchases or sales by HeartBeam, Inc. insiders were filed in the last 90 days; 41 institutions reported holding it in 13F filings for Q2 2026, worth $6.08M in total; no superinvestor holds it.
Other share classesBEATW
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 13, 2026, 1:21 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Operating expenses | $21.1M | $19.9M | $15.3M | $13.0M | $2.29M |
| Research and development | $13.4M | $11.1M | $6.80M | $5.68M | $255.0K |
| Selling, general and administrative | $7.69M | $8.84M | $8.52M | $7.35M | $2.03M |
| Operating income | -$21.1M | -$19.9M | -$15.3M | -$13.0M | -$2.29M |
| Interest expense | – | – | – | – | $2.17M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$21.0M | -$19.4M | -$14.6M | -$13.0M | -$4.43M |
| EPS, basic | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 |
| EPS, diluted | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 |
| Weighted shares, basic | 33.7M | 26.6M | 20.3M | 8.17M | 4.28M |
| Weighted shares, diluted | 33.7M | 26.6M | 20.3M | 8.17M | 4.28M |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Cash and equivalents | $4.38M | $2.38M | $16.2M | $3.59M | $13.2M |
| Inventory | $103.0K | – | – | – | – |
| Total current assets | $4.68M | $2.77M | $16.8M | – | – |
| Property, plant and equipment | $1.10M | $450.0K | $256.0K | – | – |
| Total assets | $5.84M | $3.28M | $17.1M | $4.04M | $14.0M |
| Accounts payable | $1.05M | $531.0K | – | – | – |
| Total liabilities | $3.24M | $1.62M | $1.19M | $1.67M | $588.0K |
| Shareholders' equity | $2.60M | $1.65M | $15.9M | $2.37M | $13.4M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Operating cash flow | -$14.0M | -$14.5M | -$12.1M | -$9.95M | -$3.23M |
| Capital expenditures | $600.0K | $201.0K | $256.0K | – | – |
| Free cash flow | -$14.6M | -$14.7M | -$12.3M | – | – |
| Stock-based compensation | $5.15M | $4.30M | $3.21M | $1.12M | $192.0K |
| Investing cash flow | -$600.0K | -$201.0K | -$256.0K | – | – |
| Financing cash flow | $16.6M | $866.0K | $25.0M | $350.0K | $16.4M |
| Net change in cash | $2.00M | -$13.8M | $12.6M | -$9.60M | $13.2M |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 10, 2026 | 63.3M | +83.8% | SEC |
| Aug 11, 2026 | 56.3M | +64.2% | SEC |
| May 11, 2026 | 55.5M | +64.2% | SEC |
| Mar 11, 2026 | 41.1M | +21.8% | SEC |
| Nov 11, 2025 | 34.4M | +29.2% | SEC |
| Aug 11, 2025 | 34.3M | +29.2% | SEC |
| May 9, 2025 | 33.8M | +28.4% | SEC |
| Mar 11, 2025 | 33.7M | +28.1% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.